Advanced Search

Show simple item record

dc.contributor.authorBadak, Özer
dc.contributor.authorDemir, Ali Rıza
dc.contributor.authorÖnal, Tugay
dc.contributor.authorAkgün, Taylan
dc.contributor.authorYontar, Osman Can
dc.contributor.authorŞatıroğlu, Ömer
dc.contributor.authorDuman, Hakan
dc.contributor.authorOkuyan, Ertuğrul
dc.contributor.authorMelek, Mehmet
dc.contributor.authorDural, İbrahim Etem
dc.identifier.citationBadak, Ö., Demir, A. R., Önal, T., Akgün, T., Yontar, O. C., Şatıroğlu, Ö., ... & Dural, İ. E. (2022). Assessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC). IJC Heart & Vasculature, 39, 100989.en_US
dc.description.abstractBackground and Aim Despite the advances in oral anticoagulation with NOACs, careful patient and dose selection is required with NOAC therapy. Our study aimed to assess treatment patterns of NOACs in AF along with patients’ continuity to NOAC treatments in first year, and their knowledge level of AF and NOAC treatment. Methods ASPECT-NOAC was designed as an observational, prospective, and multicenter study. AF patients who were prescribed NOACs within last four months were recruited from 34 outpatient cardiology clinics covering all geographic regions of Turkey. Baseline data were collected initially whereas patient awareness was evaluated at 3 to 4 weeks. Final study visit was performed at 12 months. Results In total, 991 patients were included to the study. Mean ± standard deviation of age was 69.4 ± 10.2 years and 53.0% of patients were female. Mean duration from AF diagnosis was 24.9 ± 50.9 months. Mean CHA 2 DS 2 -VASc and HAS-BLED scores were 3.1 ± 1.5 and 1.6 ± 1.1, respectively. AF disease and NOAC treatment knowledge levels were found to be 48.9 ± 23.1% and 73.0 ± 19.3%, respectively. Among reduced dose users 71.4% of patients were prescribed inappropriate reduced doses. Through the study follow-up, 32 patients (3.2%) deceased and NOAC therapy was discontinued in 74 patients (8.7%). Conclusion AF patients who recently started NOAC treatment in Turkey were found to have variable knowledge about their disease and anticoagulation treatment. It was observed that most of the patients continued the NOAC treatment throughout the study. Reduced dosing of NOACs was common, which was associated with higher baseline risk for bleeding as well as stroke.en_US
dc.subjectAtrial fibrillationen_US
dc.subjectNon-vitamin K oral anticoagulantsen_US
dc.subjectPatient characteristicsen_US
dc.subjectPatient knowledgeen_US
dc.subjectTreatment continuityen_US
dc.subjectTreatment patternsen_US
dc.titleAssessment of treatment patterns and patient awareness in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (ASPECT-NOAC)en_US
dc.departmentAFSÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalıen_US
dc.contributor.institutionauthorDural, İbrahim Etem
dc.relation.journalInternational Journal of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US

Files in this item


This item appears in the following Collection(s)

Show simple item record